MENU
GYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gyre Therapeutics (GYRE) Ownership - Who owns Gyre Therapeutics?
Profile
Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 619 949-3681
Employees
4
Web
https://www.gyretx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.34B
P/E Ratio
N/A
Total Cash
25.1M
Projected Growth
N/A
Total Debt
1.96M
Revenue
111.59M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.27
Total Debt/Equity
N/A
Revenue/Share
1.30 USD as % of share price
Fundamentals
GYRE
Capitalization
1.34B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
25.1M
Total Cash/Share
0.27
Total Debt
1.96M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.30%
Revenue
112M
ROE
N/A
Book Value
60.4M
P/B Ratio
21.74
Cash Flow
N/A
Earnings
-1.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
85K
Current Ratio
3.44
Current Revenue Per Employee
64514.07
Dividends Per Share - Security
N/A
EBITDA
20.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.95
Revenue To Assets
-71.09
Shares Held By Institutions
23M
Shares Outstanding - Current
93.4M
Total Liabilities
27.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
-45.387
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 619 949-3681
Employees
4
Web
https://www.gyretx.com